Thompson David Blair’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$541K Buy
451
+72
+19% +$73.6K 0.27% 117
2026
Q1
$349K Sell
379
-534
-58% -$541K 0.2% 124
2025
Q4
$981K Buy
+913
New +$873K 0.56% 53
2024
Q4
$1.02M Buy
+1,317
New +$1.09M 0.74% 35

Other funds holding LLY

Thompson David Blair's LLY Position: Q2 2026 in Review

Thompson David Blair increased its Eli Lilly (LLY) stake by 19% in Q2 2026, buying an estimated $73.6K and bringing the position to 451 shares worth $541K. The position accounts for 0.27% of the portfolio, ranked #117.

Thompson David Blair first reported a position in LLY in Q4 2024 and has held it in 4 quarters since. The position peaked at $1.02M in Q4 2024. 4,431 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Thompson David Blair held 451 shares of Eli Lilly worth $541K as of Q2 2026.
  • Thompson David Blair bought 72 Eli Lilly shares in Q2 2026, an estimated $73.6K.
  • Eli Lilly made up 0.27% of Thompson David Blair's portfolio in Q2 2026, its #117 holding.
  • Thompson David Blair first reported a position in Eli Lilly in Q4 2024 and has held it in 4 quarters since.
  • Thompson David Blair's Eli Lilly position peaked at $1.02M in Q4 2024.
  • 4,431 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Thompson David Blair's 13F filing for Q2 2026, filed 14 Aug 2026.